Related Experiment Video
Updated: Sep 2, 2025
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy
Yaotai Wang1, Yu Tang1, Yan Du2
1State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China; Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
This study developed a novel system using genetically engineered bacteria and multi-functional nanoparticles to improve focused ultrasonic ablation surgery (FUAS) for tumor treatment. This synergistic approach enhances tumor targeting, multimodal imaging, and therapeutic efficiency, overcoming FUAS limitations.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Focused ultrasonic ablation surgery (FUAS) shows promise for non-invasive tumor treatment but faces challenges in therapeutic efficiency due to poor tumor targeting, limited imaging, and recurrence.
- Existing FUAS limitations necessitate innovative strategies to enhance tumor specificity and treatment outcomes.
Purpose of the Study:
- To develop a synergistic biological targeting system combining genetically engineered bacteria and multi-functional nanoparticles to overcome FUAS limitations.
- To improve tumor targeting, multimodal imaging, and therapeutic efficacy in FUAS through a novel engineered bacteria-nanoparticle platform.
Main Methods:
- Genetically engineered Escherichia coli to produce gas vesicles (GVs) for tumor targeting and acoustic reporting.
- Developed multi-functional cationic lipid nanoparticles co-loaded with IR780, perfluorohexane, and banoxantrone dihydrochloride (AQ4N).
- Investigated synergistic effects of bacteria-mediated nanoparticle delivery, FUAS, and hypoxia-activated chemotherapy in a murine tumor model.
Main Results:
- Genetically engineered GVs-E. coli successfully colonized tumors, enabling ultrasound imaging and FUAS guidance.
- Multi-functional nanoparticles were effectively enriched in tumors via electrostatic adsorption, facilitating targeted imaging and therapy.
- The combined approach demonstrated enhanced tumor ablation and synergistic therapeutic effects, with AQ4N activated by tumor hypoxia.
Conclusions:
- The developed genetically engineered bacteria-mediated multifunctional nanoparticle system significantly improves FUAS efficacy by addressing tumor targeting, imaging, and recurrence issues.
- This synergistic strategy offers a promising platform for advanced tumor therapy, integrating targeted ablation, chemotherapy, and multimodal monitoring.
- The approach represents a significant advancement in overcoming the limitations of current FUAS treatments for improved patient outcomes.
